
The Rotting Copper of Public Health: AMR Threats and the CDC's Metabolic Pivot
The WHO's classification of a novel CRE strain alongside the CDC's 40% funding pivot to metabolic health exposes a severe structural misalignment in g...
Read Full Story →
![[The Latency Arbitrage: CRISPR Point-of-Care Diagnostics and the Disruption of the PCR Monopoly]](https://www.crimaz.com/assets/images/no-image.png)

